| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
|
Forget, Antoine
|
|
2018
|
34 |
3 |
p. 379-395.e7
|
article
|
| 2 |
Cytosolic DNA Sensing in Organismal Tumor Control
|
Vanpouille-Box, Claire
|
|
2018
|
34 |
3 |
p. 361-378
|
article
|
| 3 |
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
|
Mancini, Andrew
|
|
2018
|
34 |
3 |
p. 513-528.e8
|
article
|
| 4 |
Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity
|
Dravis, Christopher
|
|
2018
|
34 |
3 |
p. 466-482.e6
|
article
|
| 5 |
GABPβ1L Wakes Up TERT
|
Rahme, Gilbert J.
|
|
2018
|
34 |
3 |
p. 358-360
|
article
|
| 6 |
Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence
|
Boyd, Allison L.
|
|
2018
|
34 |
3 |
p. 483-498.e5
|
article
|
| 7 |
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses
|
Stewart, Elizabeth
|
|
2018
|
34 |
3 |
p. 411-426.e19
|
article
|
| 8 |
Location, Location, Location: Mutant NPM1c Cytoplasmic Localization Is Required to Maintain Stem Cell Genes in AML
|
Uckelmann, Hannah J.
|
|
2018
|
34 |
3 |
p. 355-357
|
article
|
| 9 |
MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis
|
Brescia, Paola
|
|
2018
|
34 |
3 |
p. 453-465.e9
|
article
|
| 10 |
Multiomic Medulloblastomas
|
Rahmann, Eric P.
|
|
2018
|
34 |
3 |
p. 351-353
|
article
|
| 11 |
Mutant NPM1 Maintains the Leukemic State through HOX Expression
|
Brunetti, Lorenzo
|
|
2018
|
34 |
3 |
p. 499-512.e9
|
article
|
| 12 |
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS
|
Kitajima, Shunsuke
|
|
2018
|
34 |
3 |
p. 439-452.e6
|
article
|
| 13 |
Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups
|
Archer, Tenley C.
|
|
2018
|
34 |
3 |
p. 396-410.e8
|
article
|
| 14 |
Targeting the Residual Leukemia Cells after Chemotherapy
|
Vu, Ly P.
|
|
2018
|
34 |
3 |
p. 353-355
|
article
|
| 15 |
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
|
Razavi, Pedram
|
|
2018
|
34 |
3 |
p. 427-438.e6
|
article
|
Journal description